Blackford and Thirona Partner to Enhance Lung Image Analysis
admin2024-08-20T10:02:01+00:00Blackford and Thirona announce a commercial partnership to bring the LungQ™ solution to healthcare professionals via the Blackford Platform.
Voiant and Thirona announce commercial partnership for full scope services in imaging-based clinical trials for pulmonary diseases.
admin2024-08-20T10:07:13+00:00Voiant and Thirona have entered a global commercial partnership to provide full scope integral services for clinical trials (with AI-powered lung image analysis), building further on several years of a fruitful cooperation.
LungQ 3.0.0 receives FDA 510(k) clearance
admin2024-08-20T10:10:32+00:00Thirona has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the latest update of its AI-based clinical software LungQ™ (v3.0.0)
Aidence, Incepto, and Thirona launch joint clinical solution to support the expansion of lung cancer screening in Europe
admin2024-02-19T12:40:19+00:00MedTech companies Aidence, Incepto, and Thirona jointly introduce a comprehensive AI-powered software package for lung cancer screening and the analysis of emphysema
Thirona Raises €7,5 Million New Financing
admin2024-02-19T12:38:23+00:00Thirona is thrilled to have secured €7,5 Million ($8 Million) of financing from HERAN Partners, Borski Fund and the EIC.
Thirona awarded to receive EIC grant
admin2024-02-19T12:39:30+00:00Following the second 2023 EIC Accelerator cut-off in March, Thirona is awarded to receive European Innovation Council (EIC) funding.
Artificial Intelligence Could Enable Life-Saving Early Diagnosis and Advance the Treatment of Pulmonary Hypertension
admin2024-01-29T20:13:11+00:00Thirona’s AI-Based LungQ™AVX Reveals New Potential for Treatment of Vascular Diseases.
Thirona spins out the Retina business to pursue long-term growth plans
admin2024-08-20T10:12:18+00:00Following the growing market demand and recent expansion of RetCAD™, Thirona decided spins it out as per January 1st,
Pulmonary hypertension: ongoing research
admin2024-02-19T12:42:12+00:002 abstracts of major importance for advancing the treatment of pulmonary vascular diseases, and pulmonary hypertension in particular, were presented today at ATS 2023 International Conference in Washington by Julien Guiot from CHU de Liège.
Bringing AI into hospitals – Empowering personalized patient treatment
admin2024-01-29T20:28:46+00:00Bringing AI into clinical care through integration partnerships with Philips & Incepto.
NLAIC Matchmaking for AI Startups in Healthcare
admin2024-02-19T12:42:37+00:00On November 24th the matchmaking in healthcare event took place, organized by the Netherlands AI coalition
Predictive powers of Thirona’s CAD4COVID in COVID-19 patients
admin2024-02-01T15:29:25+00:00AI significantly increases efficiency in predicting the risk of deterioration of the COVID-19 patient’s condition.
ISO 27001 certification for Thirona assures that patients' data is handled according to stringent information security guidelines
admin2024-02-19T12:46:50+00:00Thirona is awarded ISO 27001 and NEN 7510 certifications.
ATS 2022, San Fransisco: AI in medical imaging is taking off
admin2024-02-19T12:48:18+00:00American Thoracic Society 2022 was a great opportunity to meet the respiratory expert community
Thirona appoints Chief Medical Officer
admin2024-02-19T12:49:08+00:00We are very glad to announce that prof. Tiddens has joined Thirona.
Amazon Web Services supports Thirona's innovation in diagnostic research
admin2024-02-19T12:51:28+00:00Amazon Web Services grants Thirona AWS Promotional Credit under the DDI Program.
Thirona’s artery-vein and segment segmentation helps in lung cancer surgeries
admin2024-02-19T11:28:00+00:00Read the new paper on the added value of AI-based lung segmentation and VR technology in lung cancer surgery planning.
Thirona is present at ATS and Radiology days
admin2024-02-19T11:26:28+00:00Thirona is present during the congress of the American Thoracic Society from May 14-19.
Thirona launches AI software for Cystic Fibrosis
admin2022-04-04T12:02:09+00:00Thirona developed an AI algorithm that revolutionizes cystic fibrosis (CF) care.
LUMC calculates lung damages COVID-19 patients with AI technology
admin2024-02-19T11:25:58+00:00Healthcare professionals at Leiden University Medical Centre can now use artificial intelligence to quickly and easily calculate whether a corona patient has suffered serious lung damage.
Update from Thirona
admin2024-02-19T11:24:30+00:00Due to COVID-19 further spread worldwide, we prepared an update on our work to better bridge the gap between medical image analysis and clinical use-ability.
The Canisius Wilhelmina Ziekenhuis in Nijmegen is now using CAD4COVID-CT in their clinical practice!
admin2024-02-19T11:23:40+00:00Our CAD4COVID software will help to assess affected lung tissue in COVID-19 patients.
CAD4COVID-CT is allowed by the FDA to be used in the US
admin2022-04-04T12:05:15+00:00CAD4COVID-CT can now help even more people with the permission from the FDA.
Thirona is now compliant with the new Medical Device Regulation
admin2022-06-17T13:31:53+00:00We are especially proud to announce that Thirona successfully implemented the requirements and is now certified against the new MDR.
Thirona obtains patent for quantitative analysis of Cystic Fibrosis in children
admin2024-02-19T11:23:01+00:00The patent allows Thirona to develop an AI algorithm that will analyse CT scans to identify even the smallest abnormalities in the lungs, especially early on, ensuring that the right treatment can follow.
Thirona partners with P4O2 consortium to study long-term effects of COVID-19
admin2024-02-19T11:22:20+00:00Public-private consortium P4O2 together with Thirona investigates risk factors for developing lung damage and chronic complaints after COVID-19
Thirona's CT analysis helps VR-visualization of lungs for pre-operative planning
admin2024-02-19T11:21:47+00:00MedicalVR has integrated Thirona's chest CT analysis software in their virtual reality application PulmoVR.
Thirona Teams Up with Smart Reporting to Further Improve Covid-19 Detection
admin2022-04-04T12:08:12+00:00With the COVID-19 pandemic ongoing, Thirona starts a new collaboration to further improve and accelerate the detection of the virus.
Thirona is present at the ECR
admin2024-02-19T11:21:11+00:00Thirona is present at the online congress of the European Society of Radiology (ECR) which is held from July 15-19.
CAD4COVID-XRay performs comparable to radiologists
admin2022-04-04T12:12:19+00:00Artificial intelligence tool CAD4COVID-XRay can perform comparably to radiologists in triaging suspected COVID-19 cases by analysing chest X-rays.
CAD4COVID in Top 10 innovations at UNECA Innovation Challenge
admin2022-04-04T12:13:00+00:00We are honoured that CAD4COVID has been nominated for the Top 10 innovation at COVID-19 Innovation Challenge 2020 organized by the UNECA.
RetCAD is cleared for clinical use in New Zealand
admin2022-04-04T12:14:32+00:00We look forward to working with our users in New Zealand on the analysis of their retinal images.
CAD4COVID-XRay and CAD4COVID-CT are CE certified
admin2022-04-04T12:15:17+00:00Our Notified Body has granted CE certifications for both our CAD4COVID-CT and CAD4COVID-XRay solutions.
LungQ is cleared for clinical use in South Korea
admin2022-04-04T12:15:47+00:00We look forward to working with our South Korean users on quantitative analysis of their chest CT scans.
We have launched CAD4COVID-CT
admin2022-04-04T12:16:25+00:00We are proud to launch CAD4COVID-CT, our artificial intelligence software for the analysis of COVID-19 on CT scans.
Triage for COVID-19 Using AI on Chest X-rays
admin2022-04-04T12:17:30+00:00Thirona has screened over 6 million people in 40 countries with its proven CAD4TB solution.
Happy birthday to us!
admin2024-02-19T11:20:11+00:00Thirona became 6 years old today, so it was time to celebrate with some cake.
EFRO subsidy to Thirona, RadboudUMC en Quirem
admin2024-02-19T11:19:38+00:00Thirona is in a collaboration with the RadboudUMC and Quirem in the project Radiology of the Future, sponsored by the EFRO.
Our LungQ software picks up progression in emphysema and air trapping
admin2024-02-19T11:17:58+00:00Thirona's lung quantification software picks up progression in emphysema and air trapping over 5 years in smokers with and without COPD.
RetCAD validation and approval
admin2022-04-04T12:18:53+00:00RetCAD is validated in a scientific study and is also approved for clinical use in Singapore.
Thirona starts a collaboration with UKE
admin2024-02-19T11:12:45+00:00Thirona will start a pilot study in collaboration with Dr. Toam Katz from the Medical Center Hamburg-Essendorf (UKE).
Rudolfs presented at the COPDGene 2019 fall meeting in Boston
admin2024-02-19T11:14:04+00:00Rudolfs Latisenko, data scientist at Thirona, presented our deep learning approach for reducing dose-related noise on low dose CT at the COPDGene 2019.
Thirona in de Gelderlander
admin2024-02-19T11:13:55+00:00Local newspaper "de Gelderlander" visited Thirona to talk about our research collaboration with ThiraLab (the article is in Dutch).
Thirona is present at the ERS
admin2024-02-19T11:13:35+00:00We are present at the ERS conference from 29 September until 2 October. Our booth is at V19, so come by to learn more about our ChestCT solutions. So come take a flyer and a pen!
Opening of Thira Lab
admin2024-02-19T11:04:30+00:00The Thira Lab, a collaboration between Thirona, Delf Imaging Systems and the Radboud UMC, has been opened! In this lab 6 PhD candidates and 3 post-docs will work on AI research for medical imaging with a focus on CT scans of the lungs, and Xrays of the retina and chest.
Thirona is present at the ESCRS conference
admin2024-02-19T11:13:12+00:00From 15-18 September Thirona is present at the ESCRS 2019 conference in Paris. Come and visit our booth at D141 for more information about our Retina solutions.